Company / Current Liabilities
United Therapeutics Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$560.6M
FY2025
5-year range
$305.4M / $804.4M
FY2021-FY2025
Trend
-24.0%
vs FY2024
Sector context
#33 of 213
Health Care
What the data says
United Therapeutics's current liabilities of $561M is higher than 85% of companies in the Health Care sector (FY2025). Current Liabilities has fluctuated over the past 10 years, ranging from $277M in FY2018 to $804M in FY2023.
Based on SEC 10-K filings.
$561M in FY2025 with a 5-year CAGR of +11.6%. Top quartile in the Health Care sector.
Improved from $804M to $561M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +17.8%
- 5-Year CAGR
- +11.6%
- 10-Year CAGR
- -
Sector benchmark
-64.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +11.6%, indicating consistent growth.
- In FY2025, current liabilities decreased 24.0% year-over-year.
- Ranks #33 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $560.6M | -24.0% |
| FY2024 | $738.1M | -8.2% |
| FY2023 | $804.4M | +134.4% |
| FY2022 | $343.2M | +12.4% |
| FY2021 | $305.4M | -5.5% |
| FY2020 | $323.3M | -30.2% |
| FY2019 | $463.0M | +67.4% |
| FY2018 | $276.6M | -37.8% |
| FY2017 | $444.7M | +33.7% |
| FY2016 | $332.5M | -24.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026